US 9,050,094
Application 12/407,709 · Granted Jun 9, 2015
Methods and devices for passive residual lung volume reduction and functional lung volume expansion
Estimated expiration
October 6, 2029
2y 320d remaining
Earliest effective filing
Mar 12, 2007
+ 20 years
Mar 12, 2027
PTA +939d
Oct 6, 2029
No TD
—
Final
Oct 6, 2029
- Earliest effective filing
- Mar 12, 2007
- + 20 years
- Mar 12, 2027
- PTA +939d
- Oct 6, 2029
- No TD
- —
- Final
- Oct 6, 2029
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.
Calculation details
Base term
- Filing date
- March 19, 2009
- Earliest effective filing
- March 12, 2007
- Issue date
- June 9, 2015
- PTA
- +939 days
- Base expiry (before PTA)
- March 12, 2027
March 12, 2007 + 20 years = March 12, 2027 + 939 PTA days = October 6, 2029
- Continuation-in-part of application PCTUS2008056706, filed Mar 12, 2008
- Continuation of application 11/685,008, filed Mar 12, 2007
Terminal disclaimers
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
You have the date. Your AI can have the file.
Application 12/407,709 · US 9,050,094
PatentReply compiles the prosecution history behind US 9,050,094: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One new published application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US9050094Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.